Company Analysis

Scilex Holding Company (SCLX)

Nasdaq: SCLX · Biological Products, (No Diagnostic Substances) · Palo Alto, CA · filing with the SEC since 2020
Grade4.1
◀ Past 4.5● Present 3.4▶ Future 4.8
1 est.

Who runs Scilex Holding Company

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Ji Henry
Exec Chair, CEO and President. First filing Nov 2022, latest Apr 20, 2026, 3 filings in all.
Officers reporting now
2
of 5 people with a filing in the last fifteen months
Directors reporting now
3
17 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Ji HenryExec Chair, CEO and PresidentNov 2022Apr 20, 2026none
Ma Stephen HoiCFO, COO and SecretarySep 2023Apr 20, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Chun JaydirectorSep 2023Oct 9, 2025none
Followwill DormandirectorNov 2022Oct 9, 2025none
Wu Yue AlexanderdirectorSep 2023Oct 9, 2025none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Sclx Stock Acquisition Jv LLC10% ownerSep 2023Jul 7, 2026none
Scilex, Inc.10% ownerJun 2026Jun 26, 2026none
Scilex Holding Co10% ownerDec 2025Dec 30, 20253 · $12.8M
Earlier names on the record15, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton SCLX · research, not advice